Taiwan has never felt more significant. Long acknowledged for its extraordinary semiconductor prowess and its efficient National Health Insurance system, Taiwan’s life sciences industry has received less attention, but things are changing fast. This is not due to any single development, but the convergence of several long-building forces. Semiconductor experience is being leveraged across the…
See Full ReportInFigures
Hong Kong — Asia’s premier financial hub and the indispensable gateway between mainland China and global markets — has defied its sceptics and staged one of the most dramatic comebacks in recent memory. After enduring sluggish GDP growth, depressed stock market valuations, and a painful economic transition between 2021 and 2024, the city has roared…
See Full Report
The United States remains the undisputed global engine of scientific discovery and commercialization, accounting for approximately 40 percent of global pharmaceutical revenues. Supported by an annual public research budget exceeding USD 45 billion through the NIH, the US ecosystem is anchored by world-class hubs in Massachusetts, California, and New Jersey. However, this dominance is being…
See Full Report
France’s healthcare and life sciences sector enters 2026 with cautious momentum. With the annual budget finally making its way through the French parliament, stakeholders can look forward to the year ahead in Europe’s second-largest market with increased certainty. And, as this exclusive new report shows, there is plenty to be optimistic about. Healthcare & Life…
See Full Report
Latin America enters 2026 in a state of sharp contradiction. Healthcare and life sciences capabilities are expanding in scale and strategic relevance, even as political volatility and economic uncertainty remain structural features of the region. Recent geopolitical tensions and sanctions rhetoric have once again highlighted how exposed healthcare systems are to currency swings, procurement disruption,…
See Full Report
Switzerland stands as one of the world’s foremost life science hubs, combining scientific depth, industrial strength, and a uniquely collaborative ecosystem. The country hosts a powerful axis of biopharma, diagnostics, and advanced manufacturing stretching from Basel through Zurich, Zug and Rotkreuz, supported by global and regional headquarters, leading R&D centres, and an exceptional talent base.…
See Full Report
In the global health and life sciences landscape, Denmark has emerged as a small country with an outsized voice – not only through its scientific and industrial achievements, but also through its collaborative, values-based approach to health innovation and policymaking. As Denmark holds the presidency of the Council of the European Union for the remainder…
See Full Report
In the global pharmaceutical supply chain, one small Caribbean island punches far above its weight. The US jurisdiction of Puerto Rico – just 100 miles by 35 miles – out-exports every individual US state in biopharmaceuticals, shipping over USD 53 billion worth of medicines and medical devices annually to 120 countries. That’s more than twice…
See Full Report
Saudi Arabia is moving fast, thinking big and aiming high as it powers towards the goals set forth in its Vision 2030 national transformation plan. The astonishing pace and extent of change underway throughout the Kingdom is fuelling major progress within the realm of healthcare and life science. The Middle East’s largest country and its…
See Full Report
Mexico’s healthcare and life sciences sector is at a pivotal moment. As a country with deep manufacturing expertise, a rapidly evolving regulatory landscape, and a strategic position at the heart of North America, Mexico is both a regional powerhouse and a critical player in the global healthcare ecosystem. But with opportunity comes challenge, and 2025…
See Full Report
China’s position as one of the top global sources and recipients of biopharmaceutical innovation is inarguable. As the Year of the Dragon draws to a close, leading Chinese life sciences stakeholders remain undimmed in their commitment to the country and the myriad opportunities to bring breakthroughs to patients, both within China’s borders and beyond. Healthcare…
See Full Report
Switzerland stands tall as a global powerhouse in healthcare and life sciences, a nation where innovation and precision converge to shape the future of medicine. With its thriving biotech ecosystem, groundbreaking research, and advanced manufacturing capabilities, Switzerland remains the gold standard in Europe—punching far above its weight for a country of just 8.5 million. Home…
See Full Report